Keyphrases
Acetylcholinesterase Inhibitors (AChEI)
100%
Active Placebo
16%
Active Treatment
16%
Alzheimer's Disease
100%
Alzheimer's Disease Patient
16%
Atypical Antipsychotics
16%
Behavioral Disturbances
100%
Behavioral Effects
16%
Behavioral Symptoms
16%
Blanket
16%
Clinical Features
16%
Clinical Trials
16%
Cochrane Library
16%
Dementia
16%
Embase
16%
MEDLINE
16%
Moderate to Severe
16%
Moderating Effect
16%
Neuropsychiatric Inventory Questionnaire (NPI-Q)
16%
Neuropsychiatric Symptoms
33%
Randomized Placebo-controlled Trial
16%
Selection Criteria
16%
Treatment Effect
16%
Medicine and Dentistry
Acetylcholinesterase Inhibitor
100%
Alzheimer's Disease
100%
Atypical Antipsychotics
16%
Behavioral Effect
16%
Clinical Feature
16%
Clinical Trial
16%
Neuropsychiatric Inventory
16%
Patient with Alzheimer's Disease
16%
Placebo
33%
Systematic Review
100%
Treatment Effect
16%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
100%
Atypical Antipsychotics
14%
Behavior Disorder
100%
Behavioral Effect
14%
Cholinesterase Inhibitor
100%
Clinical Feature
14%
Clinical Trial
14%
Placebo
28%
Neuroscience
Acetylcholinesterase Inhibitor
100%
Alzheimer's Disease
100%
Atypical Antipsychotic
14%
Behavior Disorder
100%
Behavioral Effect
14%
Placebo
28%